Thursday, January 24, 2008

Updated NORML Report Highlights The Role Of Pot In Moderating Disease Progression -- ‘Emerging Clinical Applications’ Booklet Reviews Nearly 200 Studi

The Role Of Pot In Moderating Disease Progression

Washington, DC: Clinical and preclinical research on the therapeutic use of cannabis indicates that cannabinoids may curb the progression of various life-threatening diseases – including multiple sclerosis (MS), Alzheimer’s disease, and brain cancer, according to an updated report published today by the NORML Foundation.

The revised report reviews nearly 200 scientific trials assessing the therapeutic utility of cannabinoids for the treatment of seventeen specific disease indications: Alzheimer's disease, Amyotrophic Lateral Sclerosis (ALS), diabetes mellitus, dystonia, fibromyalgia, gastrointestinal disorders, gliomas, hepatitis C, human immunodeficiency virus (HIV), hypertension, incontinence, multiple sclerosis, osteoporosis, pruritis, rheumatoid arthritis, sleep apnea, and Tourette's syndrome.


No comments:

Post a Comment

Your spam will not get posted on my blog. No wizetrade spammers etc

Subscribe to "The $t0ckman" via email

Enter your email address:

Delivered by FeedBurner